Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227792 · ClinicalTrials.gov registry record · NA
Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
A NA study of Head and Neck Carcinoma, sponsored by Yvonne Mowery.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT07227792 is a NA study of Head and Neck Carcinoma that is actively recruiting participants, run by Yvonne Mowery. The registered enrollment target is 35 participants, below the 412-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07227792, a NA study of Head and Neck Carcinoma, is actively recruiting participants, sponsored by Yvonne Mowery.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Our institution recently began incorporating a novel "tongue-out" radiation therapy (TORT) technique for patients with head and neck tumors at particular subsites (oropharynx, larynx, hypopharynx). Protruding the tongue, i.e. "tongue-out" position, induces anatomical changes that facilitate decreased radiation dose to the oral tongue and PCM. The long-term goal is to determine whether TORT results in reduced severity and faster recovery from acute treatment-related toxicities (particularly mucositis, dysphagia, and dysgeusia) and improved long-term swallowing function and taste compared to traditional "tongue-in" RT for patients with HNC.
Conditions Studied
Interventions
- RADIATION Tongue-out radiation therapy (TORT)
Study Locations (1)
Pennsylvania
- UPMC Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-11-23 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07227792
The ClinicalTrials.gov registry entry for NCT07227792 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 412-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (92% lower). The listed sponsor is Yvonne Mowery, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Tongue-out radiation therapy (TORT) is the first listed.
NCT07227792 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07227792 about?
NCT07227792 is a clinical study titled "Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer". Our institution recently began incorporating a novel "tongue-out" radiation therapy (TORT) technique for patients with head and neck tumors at particular subsites (oropharynx, larynx, hypopharynx). Protruding the tongue, i.e. "tongue-out" position, induces anatomical changes that facilitate decrease...
What is the current status of trial NCT07227792?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-11-23. Estimated completion is 2029-01-31.
What conditions does trial NCT07227792 study?
This clinical trial studies the following conditions: Head and Neck Carcinoma.
What interventions are being tested in trial NCT07227792?
The interventions under investigation include: Tongue-out radiation therapy (TORT) (RADIATION).
Who is sponsoring clinical trial NCT07227792?
This trial is sponsored by Yvonne Mowery, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227792 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
RECRUITING · NA
-
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)
RECRUITING · NA
-
Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers
RECRUITING · NA
-
Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.